Skip to main content
M.D. Florida· 9/25/2015

Small v. Amgen, Inc.

Citations

  • 134 F. Supp. 3d 1358
  • 2015 U.S. Dist. LEXIS 129195
  • 2015 WL 5687668

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • “Plaintiffs have not identified, nor has this Court found, any cases supporting their theory that FDA regulations ‘inactivate’ the learned intermediary doctrine.” (footnote omitted)
  • “[T]he Court concludes that defendants’ duty to warn of the risks associated with the use of Enbrel ran to Ms. Small’s physician, not Ms. Small.”
  • “In fact, the courts that have addressed similar arguments have all concluded that the learned intermediary doctrine is not abrogated by the medication guide regulations.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Steele

Read full opinion on CourtListener

Cited by

2 cases in this archive cite this case.

Cites

36 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases with this name

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.